When surveyed by the Faculty Senate in October 2012, nearly a third of faculty members at MD Anderson Cancer Center who responded said they were likely to leave the institution within three years.
On Jan. 30, somebody will have to climb to the top of Orlando Health's 10-story Charles Lewis Pavilion to cover up—or start removing—the backlit letters that, with a halo effect created by LED lights, broadcast the health system's affiliation with MD Anderson Cancer Center.
It takes a few clicks to look up the name of a company that holds the “Abbreviated New Drug Application,” or ANDA, to make a generic drug. Alas, this information is of little value.
